J AM ACAD DERMATOL 润色咨询

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

出版年份:1979 年文章数:2704 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:8.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后建议修改为research letter,各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后,每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗?谢谢各位~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了,还是submission to journal,有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀,我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗,我想问一下这个要怎么添加共同一作和共通讯啊,填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process,是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向:激光<br>经验分享:提交了以后需要每个作者通过邮件里面的网址确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0<br>经验分享:不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=)]
    2024-04-30 1de0ba61m50(暂无匿称) 来自青海省

    皮肤病个案有推荐的杂志吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后建议修改为research letter,各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后,每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗?谢谢各位~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了,还是submission to journal,有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀,我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗,我想问一下这个要怎么添加共同一作和共通讯啊,填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process,是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向:激光<br>经验分享:提交了以后需要每个作者通过邮件里面的网址确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0<br>经验分享:不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=)]
    2024-04-30 1de0ba61m50(暂无匿称) 来自青海省

    皮肤病个案有推荐的杂志吗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后建议修改为research letter,各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后,每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗?谢谢各位~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了,还是submission to journal,有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀,我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗,我想问一下这个要怎么添加共同一作和共通讯啊,填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process,是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向:激光<br>经验分享:提交了以后需要每个作者通过邮件里面的网址确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0<br>经验分享:不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=)]
    2023-12-10 ms9000001314913623 来自山西省

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:投稿后建议修改为research letter,各位同仁怎么看

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后建议修改为research letter,各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后,每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗?谢谢各位~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了,还是submission to journal,有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀,我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗,我想问一下这个要怎么添加共同一作和共通讯啊,填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process,是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向:激光<br>经验分享:提交了以后需要每个作者通过邮件里面的网址确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0<br>经验分享:不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=)]
    2022-11-22 ms9000001195231403

    请问提交了文章以后,每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗?谢谢各位~

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后建议修改为research letter,各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后,每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗?谢谢各位~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了,还是submission to journal,有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀,我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗,我想问一下这个要怎么添加共同一作和共通讯啊,填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process,是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向:激光<br>经验分享:提交了以后需要每个作者通过邮件里面的网址确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0<br>经验分享:不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=)]
    2022-05-31 中中y

    提交4,5天了,还是submission to journal,有人知道这是啥情况嘛

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后建议修改为research letter,各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后,每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗?谢谢各位~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了,还是submission to journal,有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀,我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗,我想问一下这个要怎么添加共同一作和共通讯啊,填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process,是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向:激光<br>经验分享:提交了以后需要每个作者通过邮件里面的网址确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0<br>经验分享:不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=)]
    2022-11-09 ms1000000155957628

    请问有没有投过基础研究的呀,我找了好久发现国人投到JAAD基本都是临床研究为主诶

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后建议修改为research letter,各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后,每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗?谢谢各位~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了,还是submission to journal,有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀,我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗,我想问一下这个要怎么添加共同一作和共通讯啊,填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process,是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向:激光<br>经验分享:提交了以后需要每个作者通过邮件里面的网址确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0<br>经验分享:不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=)]
    2022-11-08 ms1000000155957628

    请问有投过JAAD的小伙伴吗,我想问一下这个要怎么添加共同一作和共通讯啊,填信息那一栏都没有相关选项

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后建议修改为research letter,各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后,每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗?谢谢各位~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了,还是submission to journal,有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀,我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗,我想问一下这个要怎么添加共同一作和共通讯啊,填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process,是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向:激光<br>经验分享:提交了以后需要每个作者通过邮件里面的网址确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0<br>经验分享:不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=)]
    2022-10-30 ms4000000613289763

    请问投稿10天状态直接变成Decession in process,是要被拒稿了吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后建议修改为research letter,各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后,每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗?谢谢各位~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了,还是submission to journal,有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀,我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗,我想问一下这个要怎么添加共同一作和共通讯啊,填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process,是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向:激光<br>经验分享:提交了以后需要每个作者通过邮件里面的网址确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0<br>经验分享:不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=)]
    2022-06-13 起云

    偏重的研究方向:激光
    经验分享:提交了以后需要每个作者通过邮件里面的网址确认吗?

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后建议修改为research letter,各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后,每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗?谢谢各位~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了,还是submission to journal,有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀,我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗,我想问一下这个要怎么添加共同一作和共通讯啊,填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process,是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向:激光<br>经验分享:提交了以后需要每个作者通过邮件里面的网址确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0<br>经验分享:不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=)]
    2022-06-02 中中y

    审稿速度:1.0
    经验分享:不接受个案

    1

    展开1条回复
共41条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分